Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197404 · ClinicalTrials.gov registry record · Phase 2
Affect Management for Early Adolescents
A Phase 2 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 420
- Enrollment target
NCT01197404: Completed Phase 2 study, sponsored by Rhode Island Hospital.
NCT01197404 is a Phase 2 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 420 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (216% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01197404, a Phase 2 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 420 participants
- Enrollment target
Study Summary
Adolescents are at risk for HIV because of sexual and drug use behavior initiated during early adolescence, and those with mental health problems appear to be particularly susceptible. Problems with managing emotions may make it difficult for early adolescents to make good decisions about sexual and substance use behaviors. This project will develop and evaluate interventions for early adolescents with mental health issues. An intervention focused on teaching affect management skills will be compared to an intervention addressing a variety of health topics to determine which intervention best reduces risk behavior among this at-risk population.
Interventions
- BEHAVIORAL General Health Promotion
- BEHAVIORAL Affect Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
What the finished NCT01197404 record still lists
NCT01197404 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (216% higher).
The record links to 0 conditions, and to 2 interventions - of which General Health Promotion is the first listed.
NCT01197404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01197404 about?
NCT01197404 is a clinical study titled "Affect Management for Early Adolescents". Adolescents are at risk for HIV because of sexual and drug use behavior initiated during early adolescence, and those with mental health problems appear to be particularly susceptible. Problems with managing emotions may make it difficult for early adolescents to make good decisions about sexual and...
What is the current status of trial NCT01197404?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 420 participants. The study started on 2009-08. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01197404?
The interventions under investigation include: General Health Promotion (BEHAVIORAL), Affect Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT01197404?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01197404's enrollment target sits among peer trials
420 91st of 2000 higher than 1,910 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia